Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
F Mizorogi
ResearcherPublications, citations & collaboration network
F Mizorogi is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 21 works, 274 citations, an h-index of 6 and an i10-index of 4.
21
Works
274
Citations
6
h-index
4
i10-index
IDs:OpenAlex
How has F Mizorogi's publication output changed over time?
ScholarIQpublication output · 1978–2004
Output grew0% over the shown period — from 1 works in 1978 to 1 in 2004.
1
1
1
1
1
3
1
1
19781983198619921996200020022004
What are the most-cited papers on F Mizorogi?
ScholarIQmost cited works
Hepatitis C Virus Infection in Patients with B-cell Non-Hodgkin's Lymphoma.
F Mizorogi, Jun Hiramoto, Akiyo Nozato, Yoshifusa TAKEKUMA, Kazuo Nagayama, Teruji Tanaka, K Takagi
S154471048. 2000119 CitationsOPEN ACCESS
Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505
Kuniaki Itoh, T. Ohtsu, Haruhiko Fukuda, Yusuke Sasaki, Michinori Ogura, Y Morishima, Ting‐Chao Chou, Kohsuke Aikawa, Naokuni Uike, F Mizorogi, Tatsuharu Ohno, Shu‐ichi Ikeda, T. Sai, Masafumi Taniwaki, Fumiko Kawano, Miyuki Niimi, T Hotta, M Shimoyama, Kensei Tobinai
Annals of Oncology. 200258 Citations
The Production of Colony-Stimulating Factors by Thyroid Carcinoma Is Associated with Marked Neutrophilia and Eosinophilia.
Tetsuya Nakada, Hiromitsu Sato, Fuyuhiko Inoue, F Mizorogi, Kazuo Nagayama, Teruji Tanaka
S154471048. 199638 CitationsOPEN ACCESS
Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects
Setsuko Akizuki, F Mizorogi, Tomoo Inoue, Kazuki Sudo, Akihiro Ohnishi
S183182149. 200031 Citations
Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301
T Takenaka, Kuniaki Itoh, Takayo Suzuki, Atae Utsunomiya, Shin Matsuda, Takaaki Chou, Toshiaki Sai, Masayuki Sano, Susumu Konda, Tatsuji Ohno, C Mikuni, Kijoh Deura, Takashi Yamada, F Mizorogi, H Nagoshi, Masao Tomonaga, Tomomitsu Hotta, Kohichi Kawano, Keitaro Tsushita, Masami Hirano, M Shimoyama, Lymphoma Study Group
International Journal of Hematology. 20049 Citations
Related on ScholarIQ
Hepatitis C Virus Infection in Patients with B-cell Non-Hodgkin's Lymphoma.
Paper
Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505
Paper
The Production of Colony-Stimulating Factors by Thyroid Carcinoma Is Associated with Marked Neutrophilia and Eosinophilia.
Paper
Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects
Paper
Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301
Paper
Randomized Comparison of Mobilization Kinetics of Circulating CD34+ Cells Between Biweekly CHOP and Dose-Escalated CHOP with the Prophylactic Use of Lenograstim (Glycosylated rHuG-CSF) in Aggressive Non-Hodgkin's Lymphoma
Paper